WebDec 12, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 8-K Material Event for the period ending Tuesday, December 11, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 8-K Material Event Wed Dec 12 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. WebDec 17, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-K Annual report for the fiscal year ending Monday, September 30, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-K Annual Report Mon Dec 16 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades.
Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly …
WebMar 31, 2024 · Latest SEC filings for Citius Pharmaceuticals, Inc. (CTXR). Seeking Alpha - Go to Homepage Entering text into the input field will update the search … WebFeb 10, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 8-K Material Event for the period ending Friday, February 10, 2024 homes for sale in baytowne wharf fl
Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly …
WebFeb 11, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly report for the period ending Thursday, December 31, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-Q Quarterly Report Thu Feb 11 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. WebAug 11, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly Report for the period ending Thursday, June 30, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-Q Quarterly Report Thu Aug 11 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. WebApr 3, 2024 · Ticker: CTXR CIK: 1506251 Form Type: 8-K Corporate News Accession Number: 0001213900-23-026265 Submitted to the SEC: Mon Apr 03 2024 4:05:20 PM … hippo ornaments uk